MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2013.10.010PMID 24120476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors

  2012cited by this paper
• MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

  2012cited by this paper
• LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

  2012cited by this paper
• Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.

  2012cited by this paper
• Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer

  2012cited by this paper
• Tumorigenesis: Pushing pancreatic cancer to take off

  2012cited by this paper
• MicroRNAs involved in regulating epithelial–mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics

  2012cited by this paper
• Using the bioconductor GeneAnswers package to interpret gene lists.

  2012cited by this paper
• Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma

  2012cited by this paper
• Toward a combinatorial nature of microRNA regulation in human cells

  2012cited by this paper
• EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.

  2012cited by this paper
• DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

  2012cited by this paper
• Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

  2012cited by this paper
• Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

  2012cited by this paper
• Tumor Infiltration in the Medial Resection Margin Predicts Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma

  2012cited by this paper
• Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.

  2012cited by this paper
• MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

  2011cited by this paper
• MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma

  2011cited by this paper
• Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis

  2011cited by this paper
• A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation

  2011cited by this paper
• Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma

  2011cited by this paper
• MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

  2011cited by this paper
• Molecular signatures of pancreatic cancer.

  2011cited by this paper
• Synthetic siRNA targeting the breakpoint of EWS/Fli‐1 inhibits growth of Ewing sarcoma xenografts in a mouse model

  2011cited by this paper
• Pancreatic cancer

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• Prognostic role of microRNA‐21 in various carcinomas: a systematic review and meta‐analysis

  2011cited by this paper
• Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer

  2011cited by this paper
• Nedd4L modulates the transcription of metalloproteinase‐1 and ‐13 genes to increase the invasive activity of gallbladder cancer

  2011cited by this paper
• MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

  2010cited by this paper
• Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites

  2010cited by this paper
• Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma

  2010cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• Posttranscriptional regulation of microRNA biogenesis in animals.

  2010cited by this paper
• Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a

  2010cited by this paper
• NCBI GEO: archive for functional genomics data sets—10 years on

  2010cited by this paper
• miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.

  2010cited by this paper
• Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.

  2010cited by this paper
• Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality

  2010cited by this paper
• Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

  2010cited by this paper
• Cytoscape 2.8: new features for data integration and network visualization

  2010cited by this paper
• Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites

  2010cited by this paper
• BMC Bioinformatics BioMed Central Methodology article Regularized gene selection in cancer microarray meta-analysis

  2009cited by this paper
• Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

  2009cited by this paper
• KEGG for representation and analysis of molecular networks involving diseases and drugs

  2009cited by this paper
• Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.

  2009cited by this paper
• Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.

  2009cited by this paper
• A Compendium of Potential Biomarkers of Pancreatic Cancer

  2009cited by this paper
• The impact of microRNAs on protein output

  2008cited by this paper
• MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

  2008influential reference
• Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3' expression arrays.

  2008cited by this paper
• MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.

  2008cited by this paper
• Direct multiplexed measurement of gene expression with color-coded probe pairs

  2008cited by this paper
• Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma

  2008cited by this paper
• MicroRNAs as biomarkers and therapeutic drugs in human cancer

  2008cited by this paper
• Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

  2007cited by this paper
• The Nedd4-like family of E3 ubiquitin ligases and cancer

  2007cited by this paper
• microRNAs as oncogenes and tumor suppressors.

  2007cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

  2006influential reference
• MicroRNA signatures in human cancers

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes.

  2005cited by this paper
• Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes

  2005cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

  2004cited by this paper
• A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

  2003cited by this paper
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

  2002cited by this paper
• Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

  2001cited by this paper
• Gene Ontology: tool for the unification of biology

  2000influential reference
• Arrest of G1-S Progression by the p53-Inducible Gene PC3 Is Rb Dependent and Relies on the Inhibition of Cyclin D1 Transcription

  2000influential reference
• Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

  1999cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• Computational theranostics strategy for pancreatic ductal adenocarcinoma.

  2025cites this paper
• The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Targeting Mitochondrial microRNAs in Cardiovascular Pathologies: A New Frontier in Precision Cardiology.

  2025cites this paper
• Nanomedicine in the Diagnosis and Treatment of Pancreatic Cancer

  2025cites this paper
• Applications of gene pair methods in clinical research: advancing precision medicine

  2025cites this paper
• Budding Uninhibited by Benzimidazole 1 in pancreatic cancer: theoretical, mechanistic and bioinformatic insights

  2025cites this paper
• Identifying and validating PLAU as a potential prognostic biomarker for PDAC

  2025cites this paper
• miRNAs标志物对晚期肺鳞癌的预测价值

  2025cites this paper
• NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases

  2024cites this paper
• Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models

  2024cites this paper
• Current Understanding of Therapeutic and Diagnostic Applications of Exosomes in Pancreatic Cancer

  2024cites this paper
• RhoGDIβ inhibition via miR‐200c/AUF1/SOX2/miR‐137 axis contributed to lncRNA MEG3 downregulation‐mediated malignant transformation of human bronchial epithelial cells

  2024cites this paper
• E3 ubiquitin ligase NEDD4L negatively regulates skin tumorigenesis by inhibiting of IL-6/GP130 signaling pathway.

  2024cites this paper
• MicroRNA-130b Suppresses Malignant Behaviours and Inhibits the Activation of the PI3K/Akt Signaling Pathway by Targeting MET in Pancreatic Cancer

  2024influential citation
• Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis

  2023cites this paper
• Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma

  2023cites this paper
• The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase

  2023cites this paper
• RETRACTED ARTICLE: ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis

  2023influential citation
• Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review

  2022cites this paper
• Design of Optimal Deep Learning-Based Pancreatic Tumor and Nontumor Classification Model Using Computed Tomography Scans

  2022cites this paper
• Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?

  2022cites this paper
• Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.

  2022cites this paper
• Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer

  2022cites this paper
• Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer

  2022cites this paper
• E3 ubiquitin ligase NEDD4L negatively regulates keratinocyte hyperplasia by promoting GP130 degradation

  2021cites this paper
• An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma

  2021influential citation
• Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage

  2021cites this paper
• Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers

  2021cites this paper
• Large-scale miRNA-Target Data Analysis to Discover miRNA Co-regulation Network of Abiotic Stress Tolerance in Soybeans

  2021cites this paper
• The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis

  2021cites this paper
• Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs

  2021cites this paper
• The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer

  2021cites this paper
• Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer

  2021cites this paper
• Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma

  2021cites this paper
• Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy

  2021cites this paper
• miR‐365 secreted from M2 Macrophage‐derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis

  2021cites this paper
• MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing

  2021cites this paper
• Cell type–specific microRNA therapies for myocardial infarction

  2021cites this paper
• Translational control of enzyme scavenger expression with toxin-induced micro RNA switches

  2021cites this paper
• Prognostic value of microRNAs in pancreatic cancer: a meta-analysis

  2020influential citation
• MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways.

  2020cites this paper
• Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation

  2020influential citation
• An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer

  2020cites this paper
• Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells

  2020cites this paper
• Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma.

  2020cites this paper
• A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection

  2020cites this paper
• Interference of miR‐107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma

  2020cites this paper
• FOLFIRINOX in pancreatic cancer: from state of the art treatments to promising translational studies for personalized therapy

  2020cites this paper
• Marker Identification of the Grade of Dysplasia of Intraductal Papillary Mucinous Neoplasm in Pancreatic Cyst Fluid by Quantitative Proteomic Profiling

  2020cites this paper
• Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis

  2020cites this paper
• Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer

  2020cites this paper
• LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p.

  2020cites this paper
• Detection and diagnosis of pancreatic tumor using deep learning-based hierarchical convolutional neural network on the internet of medical things platform

  2020cites this paper
• Pancreatic cancer cell–derived exosomal microRNA‐27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2

  2019cites this paper
• Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis

  2019cites this paper
• PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression

  2019cites this paper
• Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments

  2019cites this paper
• Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis

  2019cites this paper
• A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis

  2019cites this paper
• Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets

  2019cites this paper
• Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism

  2019cites this paper
• Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features

  2019cites this paper
• Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression

  2019cites this paper
• Targeting the epigenome as a therapeutic strategy for pancreatic tumors

  2019cites this paper
• BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis.

  2019cites this paper
• Combinatorial Targeting b yMicroRNAsCo-ordinates Post-transcriptional Control of EMT Graphical

  2019cites this paper
• miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3.

  2019cites this paper
• Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer

  2019cites this paper
• UHRF1 is regulated by miR‐124‐3p and promotes cell proliferation in intrahepatic cholangiocarcinoma

  2019cites this paper
• Survey of miRNA-miRNA cooperative regulation principles across cancer types

  2019cites this paper
• Expression of selected MicroRNAs in pancreatic ductal adenocarcinoma in relation to tumor progression and patient’s outcome.

  2019cites this paper
• From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs

  2019cites this paper
• Prognostic Biomarker Identification for Pancreatic Cancer by Analyzing Multiple mRNA Microarray and microRNA Expression Datasets

  2019influential citation
• Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer

  2018influential citation
• RETRACTED: miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA

  2018cites this paper
• Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer

  2018cites this paper
• A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer

  2018cites this paper
• MiR-23a transcriptional activated by Runx2 increases metastatic potential of mouse hepatoma cell via directly targeting Mgat3

  2018cites this paper
• TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression

  2018cites this paper
• Integrative analysis of gene expression profiles reveals specific signaling pathways associated with pancreatic duct adenocarcinoma

  2018influential citation
• MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.

  2018cites this paper
• Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1

  2018cites this paper
• Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors

  2018cites this paper
• MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma

  2018cites this paper
• The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer

  2018cites this paper
• Establishment and characterization of a GES-1 human gastric epithelial cell line stably expressing miR-23a

  2018cites this paper
• Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMT.

  2018cites this paper
• Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer

  2018cites this paper
• Computationally Modeling ncRNA-ncRNA Crosstalk.

  2018cites this paper
• Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer

  2018cites this paper
• Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma

  2018cites this paper
• miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2

  2018cites this paper
• microRNAs: Novel regulators of the TGF-β pathway in pancreatic ductal adenocarcinoma

  2018cites this paper
• Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially-expressed circRNAs, lncRNAs, miRNAs and mRNAs

  2018cites this paper
• RNome in Cancer Therapy

  2018cites this paper
• MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer - A systematic review and meta-analysis.

  2017cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells

  2017cites this paper
• miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2

  2017cites this paper